Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.28 USD | +1.62% |
|
-7.24% | +25.10% |
20/06 | Sector Update: Health Care Stocks Mixed Thursday Afternoon | MT |
20/06 | ImmunityBio Shares Rise After Launch of Bladder Cancer Treatment Anktiva in US | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.10% | 434.3Cr | |
+15.58% | 12TCr | |
+16.60% | 11TCr | |
+17.73% | 2.59TCr | |
-24.33% | 1.93TCr | |
-19.35% | 1.6TCr | |
-17.95% | 1.57TCr | |
-48.32% | 1.49TCr | |
+58.78% | 1.45TCr | |
+4.91% | 1.39TCr |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Immunitybio Says Stimulated Natural Killer Cells Led to Complete Response in Leukemia Trial